Digital Pharma blog
RSS feed for the Digital Pharma blog
Roche: 'We will work to eliminate barriers to social media'
03/09/10 permalink Last month Roche broke new ground for pharma by publishing its Social Media Principles (full details of which you can find here).
The four-page document of operating procedures for staff was a bold move for a pharma company in its openness and transparency, and signified the degree to which Roche has embraced the Web 2.0 generation of communication tools.
The company even made a welcome acknowledgement that blogs, wikis and social networks “are changing the way we are communicating, interacting, and doing business – with patients, customers and other stakeholders outside Roche, but also within the Roche network”. (Read More.)
Augmented reality gateway for Bayer haemophilia site
01/09/10 permalink Bayer Healthcare has launched a new disease awareness campaign that uses augmented reality techniques to engage with its target audience.
The Questival website aims to provide information and advice on ‘real life’ issues to teenagers with haemophilia and is themed around a virtual festival.
Bayer Healthcare brand manager Tom Cleminson said: “We hope this site will be a real hit with our patients." (Read More.)
Roche asks employees to be social media 'scouts'
17/08/10 permalink Roche wants employees that use social media to be ‘scouts’ for how the company and its products are perceived online.
The Swiss pharma company today publishes its Social Media Principles, a four-page document of operating procedures for staff, and it gave Digital Pharma an exclusive preview.
One of the standout points is a requirement for its global workforce of more than 80,000 to be on the lookout for “sentiment and critical issues” when they use social media websites in a personal capacity. (Read More.)
Pfizer begins social media drive for online clinic
13/08/10 permalink Pfizer UK has turned to social media to help raise awareness of its online Man MOT male health clinic and bolster its use of traditional PR.
The free confidential advice and information service opened its virtual doors last month and will be available to men in the UK every Monday from 6pm – 11pm for the next four months.
Man MOT UK is funded by Pfizer and has the support of a number patient groups, among them Diabetes UK, Relate, the National Obesity Forum, and Heart UK. (Read More.)
Novartis rapped for Facebook sharing
10/08/10 permalink Novartis has had its knuckles rapped by the US Food and Drug Adminstration over the company’s use of social media sharing tools.
At issue is a Facebook sharing widget on the company’s US consumer website for Tasigna (nilotinib). This generated Novartis-created information about its chronic myloid leukemia drug for sharing on the popular social network.
In a letter to the manufacturer, the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) said this shared content is misleading because it “makes representations about the efficacy of Tasigna but fails to communicate any risk information associated with the use of this drug”. (Read More.)
Byte-sized roundup
04/08/10 permalink This week’s roundup includes Janssen-Cilag's YouTube success, FDA to boost social media work, Novartis iPhone profile, Pfizer on SlideShare and Sanofi ends Go Insulin campaign.
Janssen-Cilag’s Living With ADHD YouTube video has been viewed more than 75,000 times since its debut less than two months ago.
The video has attracted praise, and a measure of surprise, for allowing comments to be added and then policing them with such a light touch that users have even questioned whether the account is moderated at all. (Read More.)
Novartis game takes aim at ticks
30/07/10 permalink Novartis has launched a new online game to raise awareness of the risks posed by ticks and how to avoid the dangerous infections they can transmit.
Players of Zeck Attack have to catapult ticks at potential victims, with more points on offer for hitting people who haven’t protected themselves, either by vaccination or covering themselves suitably when outdoors.
The lighthearted game has been produced by Novartis Vaccines for the German market, where Zeckenencephalitis – tick-bourn encephalitis or TBE - is widespread in many parts of Bavaria and Baden-Wuerttemberg. (Read More.)
